{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:40:29Z","timestamp":1774597229233,"version":"3.50.1"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2020,11,6]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is progressive and irreversible neurodegenerative disorder. Current pharmacotherapy is not able to stop progression of the disease and can only improve cognitive functions. Therefore, new drugs are being sought that will slow down the development of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>Novel phosphorus and thiophosphorus tacrine derivatives 7-14 were designed, synthesized and their biological activity and molecular modeling was investigated as a new potential anti- Alzheimer\u2019s disease (AD) agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>9-Chlorotacrine was treated with propane-1,3-diamine in the presence of sodium iodide to yield N1-(1,2,3,4-tetrahydroacridin-9-yl)propane-1,3-diamine 6. Finally, it was treated with corresponding acid ester or thioester to give phosphorus or thiophosphorus tacrine derivative 7-14. All of the obtained final structures were characterized by 1H NMR, 13C NMR, 31P NMR and MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The results of the docking studies showed that the newly designed phosphorus and thiophosphorus tacrine analogs, theoretically possess AChE and BChE-binding ability. Kinetic study showed that 8 and 12 in the series proved to be more potent electric eel AChE (eeAChE) and human (hAChE) inhibitors than tacrine, where 8 inhibited eeAChE three times more than the referenced drug. The highest BChE inhibition revealed 11 and 13. The most active compounds against eeAChE, hAChE and BChE showed mixed type of inhibition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>All new synthesized compound exhibited lower toxicity against neuroblastoma cell line (SH-SY5Y) in comparison with tacrine. Two analogues in the series, 7 and 9, demonstrated lack of cytotoxicity against hepatocellular cells (hepG2).<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406415666190716115524","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T12:45:13Z","timestamp":1563281113000},"page":"947-957","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated\/ N-Tiophosphorylated Tacrine"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8228-9359","authenticated-orcid":true,"given":"Maja","family":"Przyby\u0142owska","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Gdansk University of Technology, G. Narutowicza 11\/12, 80-233 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1676-2723","authenticated-orcid":true,"given":"Iwona","family":"Inkielewicz-Stepniak","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-9161","authenticated-orcid":true,"given":"Szymon","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-8095","authenticated-orcid":true,"given":"Krystyna","family":"Dzierzbicka","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Gdansk University of Technology, G. Narutowicza 11\/12, 80-233 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4252-4297","authenticated-orcid":true,"given":"Sebastian","family":"Demkowicz","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Gdansk University of Technology, G. Narutowicza 11\/12, 80-233 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-6491","authenticated-orcid":true,"given":"Mateusz","family":"Da\u015bko","sequence":"additional","affiliation":[{"name":"Department of Inorganic Chemistry, Gdansk University of Technology, G. Narutowicza 11\/12, 80-233 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0197-4580(98)00052-9","volume":"19","author":"Berchtold N.C.","year":"1998","unstructured":"Berchtold N.C.; Cotman C.W.; Evolution in the conceptualization of dementia and Alzheimer\u2019s disease: Greco-Roman period to the 1960s. Neurobiol Aging 1998,19(3),173-189","journal-title":"Neurobiol Aging"},{"key":"ref=2","year":"2017","unstructured":"Dementia Fact sheet World Health Organization2017","journal-title":"Dementia Fact sheet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"Wimo A.","year":"2017","unstructured":"Wimo A.; Guerchet M.; Ali G.C.; Wu Y.T.; Prina A.M.; Winblad B.; J\u00f6nsson L.; Liu Z.; Prince M.; The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 2017,13(1),1-7","journal-title":"Alzheimers Dement"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5114\/fn.2013.37702","volume":"51","author":"Armstrong R.A.","year":"2013","unstructured":"Armstrong R.A.; What causes alzheimer\u2019s disease? Folia Neuropathol 2013,51(3),169-188","journal-title":"Folia Neuropathol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2174\/1570159X16666180412091908","volume":"17","author":"Przyby\u0142owska M.","year":"2019","unstructured":"Przyby\u0142owska M.; Kowalski S.; Dzierzbicka K.; Inkielewicz-St\u0119pniak I.; Therapeutic potential of multifunctional tacrine analogues. Curr Neuropharmacol 2019,17(5),472-490","journal-title":"Curr Neuropharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejmech.2014.01.060","volume":"76","author":"Bansal Y.","year":"2014","unstructured":"Bansal Y.; Silakari O.; Multifunctional compounds: Smart molecules for multifactorial diseases. Eur J Med Chem 2014,76,31-42","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1039\/C5RA25446A","volume":"6","author":"Demkowicz S.","year":"2016","unstructured":"Demkowicz S.; Rachon J.; Da\u015bko M.; Kozak W.; Selected organophosphorus compounds with biological activity. Applications in medicine. RSC Advances 2016,6(12),7101-7112","journal-title":"RSC Advances"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"Ellman G.L.","year":"1961","unstructured":"Ellman G.L.; Courtney K.D.; Andres V.; Feather-Stone R.M.; A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961,7,88-95","journal-title":"Biochem Pharmacol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1039\/C6MD00113K","volume":"7","author":"Da\u015bko M.","year":"2016","unstructured":"Da\u015bko M.; Mas\u0142yk M.; Kubi\u0144ski K.; Aszyk J.; Rachon J.; Demkowicz S.; Synthesis and steroid sulfatase inhibitory activities of N-phosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamates. MedChemComm 2016,7(6),1146-1150","journal-title":"MedChemComm"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bioorg.2011.05.001","volume":"39","author":"Szyma\u0144ski P.","year":"2011","unstructured":"Szyma\u0144ski P.; Markowicz M.; Mikiciuk-Olasik E.; Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors. Bioorg Chem 2011,39(4),138-142","journal-title":"Bioorg Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"Meng X.Y.","year":"2011","unstructured":"Meng X.Y.; Zhang H.X.; Mezei M.; Cui M.; Molecular docking: A powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 2011,7(2),146-157","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.neuropharm.2011.10.007","volume":"62","author":"Minarini A.","year":"2012","unstructured":"Minarini A.; Milelli A.; Tumiatti V.; Rosini M.; Simoni E.; Bolognesi M.L.; Andrisano V.; Bartolini M.; Motori E.; Angeloni C.; Hrelia S.; Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer\u2019s disease treatment. Neuropharmacology 2012,62(2),997-1003","journal-title":"Neuropharmacology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/cmdc.201100239","volume":"6","author":"Bartolini M.","year":"2011","unstructured":"Bartolini M.; Pistolozzi M.; Andrisano V.; Egea J.; L\u00f3pez M.G.; Iriepa I.; Moraleda I.; G\u00e1lvez E.; Marco-Contelles J.; Samadi A.; Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. ChemMedChem 2011,6(11),1990-1997","journal-title":"ChemMedChem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"Kovalevich J.","year":"2013","unstructured":"Kovalevich J.; Langford D.; Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 2013,1078,9-21","journal-title":"Methods Mol Biol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.1038\/srep13313","volume":"5","author":"Koriyama Y.","year":"2015","unstructured":"Koriyama Y.; Furukawa A.; Muramatsu M.; Takino J.; Takeuchi M.; Glyceraldehyde caused Alzheimer\u2019s disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells. Sci Rep 2015,5(1),13313","journal-title":"Sci Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00044-018-2241-6","volume":"27","author":"Kraj\u0148\u00e1kov\u00e1 L.","year":"2018","unstructured":"Kraj\u0148\u00e1kov\u00e1 L.; Pisar\u010dikov\u00e1 J.; Drajna L.; Labudov\u00e1 M.; Imrich J.; Paul\u00edkov\u00e1 H.; Ko\u017eurkov\u00e1 M.; Intracellular distribution of new tacrine analogues as a potential cause of their cytotoxicity against human neuroblastoma cells SH-SY5Y. Med Chem Res 2018,27(10),2353-2365","journal-title":"Med Chem Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3109\/14756366.2014.1003212","volume":"30","author":"Mao F.","year":"2015","unstructured":"Mao F.; Li J.; Wei H.; Huang L.; Li X.; Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer\u2019s disease. J Enzyme Inhib Med Chem 2015,30(6),995-1001","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","volume":"59","author":"Zha X.","year":"2016","unstructured":"Zha X.; Lamba D.; Zhang L.; Lou Y.; Xu C.; Kang D.; Chen L.; Xu Y.; Zhang L.; De Simone A.; Samez S.; Pesaresi A.; Stojan J.; Lopez M.G.; Egea J.; Andrisano V.; Bartolini M.; Xu Y.; Zhang L.; De Simone A.; Samez S.; Pesaresi A.; Stojan J.; Lopez M.G.; Egea J.; Andrisano V.; Bartolini M.; Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer\u2019s disease: Design, synthesis, biological evaluation, and X-ray crystallography. J Med Chem 2016,59(1),114-131","journal-title":"J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23102540","volume":"23","author":"Wu W.","year":"2018","unstructured":"Wu W.; Liang X.; Xie G.; Chen L.; Liu W.; Luo G.; Zhang P.; Yu L.; Zheng X.; Ji H.; Zhang C.; Yi W.; Synthesis and evaluation of novel ligustrazine derivatives as multi-targeted inhibitors for the treatment of Alzheimer\u2019s disease. Molecules 2018,23(10)","journal-title":"Molecules"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/0006-2952(88)90356-5","volume":"37","author":"Dogterom P.","year":"1988","unstructured":"Dogterom P.; Nagelkerke J.F.; Mulder G.J.; Hepatotoxicity of tetrahydroaminoacridine in isolated rat hepatocytes: Effect of glutathione and vitamin E. Biochem Pharmacol 1988,37(12),2311-2313","journal-title":"Biochem Pharmacol"},{"key":"ref=22","first-page":"334","volume":"21","author":"Lou G.","year":"1996","unstructured":"Lou G.; Montgomery P.R.; Sitar D.S.; Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer\u2019s disease. J Psychiatry Neurosci 1996,21(5),334-339","journal-title":"J Psychiatry Neurosci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/bbrc.1993.1003","volume":"190","author":"Roe A.L.","year":"1993","unstructured":"Roe A.L.; Snawder J.E.; Benson R.W.; Roberts D.W.; Casciano D.A.; HepG2 cells: An in vitro model for P450-dependent metabolism of acetaminophen. Biochem Biophys Res Commun 1993,190(1),15-19","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ejmech.2017.08.013","volume":"139","author":"Reddy E.K.","year":"2017","unstructured":"Reddy E.K.; Remya C.; Mantosh K.; Sajith A.M.; Omkumar R.V.; Sadasivan C.; Anwar S.; Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation. Eur J Med Chem 2017,139,367-377","journal-title":"Eur J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1021\/jm5010804","volume":"57","author":"Nepovimova E.","year":"2014","unstructured":"Nepovimova E.; Uliassi E.; Korabecny J.; Pe\u00f1a-Altamira L.E.; Samez S.; Pesaresi A.; Garcia G.E.; Bartolini M.; Andrisano V.; Bergamini C.; Fato R.; Lamba D.; Roberti M.; Kuca K.; Monti B.; Bolognesi M.L.; Multitarget drug design strategy: Quinone-tacrine hybrids designed to block amyloid-\u03b2 aggregation and to exert anticholinesterase and antioxidant effects. J Med Chem 2014,57(20),8576-8589","journal-title":"J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.12r01412","author":"Nordberg A.","unstructured":"Nordberg A.; Ballard C.; Bullock R.; Darreh-Shori T.; Somogyi M.; A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease Prim. Care Companion CNS Disord, 2013, 15(2), PCC.12r01412.","journal-title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2140","volume":"4","author":"Chen Y.","year":"2016","unstructured":"Chen Y.; Bian Y.; Sun Y.; Kang C.; Yu S.; Fu T.; Li W.; Pei Y.; Sun H.; Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors. PeerJ 2016,4","journal-title":"PeerJ"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1111\/j.1742-4658.2009.06957.x","volume":"276","author":"Pietsch M.","year":"2009","unstructured":"Pietsch M.; Christian L.; Inhester T.; Petzold S.; G\u00fctschow M.; Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile. FEBS J 2009,276(8),2292-2307","journal-title":"FEBS J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/jm300124p","volume":"55","author":"Wang Y.","year":"2012","unstructured":"Wang Y.; Guan X-L.; Wu P-F.; Wang C-M.; Cao H.; Li L.; Guo X.J.; Wang F.; Xie N.; Jiang F.C.; Chen J.G.; Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases. J Med Chem 2012,55(7),3588-3592","journal-title":"J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/jm049112h","volume":"48","author":"Rosini M.","year":"2005","unstructured":"Rosini M.; Andrisano V.; Bartolini M.; Bolognesi M.L.; Hrelia P.; Minarini A.; Tarozzi A.; Melchiorre C.; Rational approach to discover multipotent anti-Alzheimer drugs. J Med Chem 2005,48(2),360-363","journal-title":"J Med Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/173537","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/173537\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/173537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T00:44:27Z","timestamp":1721522667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/173537\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,11,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406415666190716115524","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}